Zobrazeno 1 - 10
of 37
pro vyhledávání: ''
Autor:
Ronit Gurion, Uri Rozovski, Uri Abadi, Pia Raanani, Lee Peled, Martin Ellis, Pnina Rotman-Pikielny
Publikováno v:
Leukemia & Lymphoma. 60:2922-2926
The reported prevalence of hypercalcemia at diagnosis in non-Hodgkin-lymphoma ranges between 1.3% and 7.4%. These studies included all patients, regardless of lymphoma subtype. We performed a retrospective case-control study to determine the prevalen
Autor:
Jiali Huo, Yizhou Zheng, Shihong Lu, Min Wang, Jun Shi, Yahong You, Jinbo Huang, Neng Nie, Yingqi Shao, Zhendong Huang, Xingxin Li, Meili Ge, Jing Zhang
Publikováno v:
Leukemia & Lymphoma. 59:950-957
Acquired bone marrow failure syndromes (aBMFS) encompass a wide range of diseases. A study to investigate WT1 expression in BM was conducted in 387 patients with aBMFS in China. The WT1 level in patients with aplastic anemia (AA) was significantly lo
Autor:
Irene Luna, Mariam Ibáñez, Mar Tormo, José Cervera, Blanca Navarro, Ivan Martin, Laia Pedrola, Esperanza Such, Eva Villamón, Silvestre Oltra, Ana Vicente, Guillermo Sanz, Inés Gómez-Seguí, Miguel A. Sanz, María López-Pavía
Publikováno v:
Leukemia & Lymphoma. 58:1686-1693
The incidence of SF3B1 mutations in patients with RARS is high. Recently, it has been shown that SF3B1 and DNMT3A mutations overlap more often than expected, although it is not clear how this could affect the disease. We studied SF3B1 and DNMT3A in 1
Autor:
Nikolaos Kanellias, Magdalini Migkou, Despoina Kalapanida, Efstathios Kastritis, Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Dimitrios Christoulas, Flora Zagouri, Evangelos Terpos, Maria Roussou
Publikováno v:
Leukemia & Lymphoma. 57:1776-1780
To compare the outcomes of patients with relapsed or refractory multiple myeloma (RRMM) who were treated with lenalidomide combined with high versus low dose of dexamethasone. One hundred forty consecutive relapsed or refractory multiple myeloma (RRM
Autor:
Akiko Matsushita, Sumie Tabata, Noboru Yonetani, Takayuki Ishikawa, Yuichiro Ono, Yukihiro Imai, Nobuhiro Hiramoto, Yotaro Ochi, Satoshi Yoshioka
Publikováno v:
Leukemia & Lymphoma. 57:1945-1948
The number of patients receiving chronic dialysis is increasing worldwide.[1] Patients receiving chronic dialysis have a higher risk of developing some kinds of malignant tumors, including hematolo...
Autor:
Graham W. Slack, Edward G. Brooks, Richard Klasa, Laurie H. Sehn, Diego Villa, Randy D. Gascoyne, Tamara Shenkier, Joseph M. Connors, Alina S. Gerrie, Kerry J. Savage, Brian Skinnider
Publikováno v:
Leukemia & Lymphoma. 57:872-879
The impact of treatment delays on outcomes in Hodgkin lymphoma (HL) is currently unknown. Time from definitive histologic diagnosis to first ABVD treatment (TDT) was calculated in 810 adults with HL: 365 (45%) TDT ≤4 weeks, 369 (46%) TDT 5-8 weeks,
Autor:
Jin Seok Kim, Ji Eun Jang, June-Won Cheong, Jung Yeon Lee, Yundeok Kim, Woo Ick Yang, Yoo Hong Min, Soo Jeong Kim, Doh Yu Hwang
Publikováno v:
Leukemia & Lymphoma. 57:51-57
Few studies have evaluated the risk factors for hepatic sinusoidal obstructive syndrome (SOS) in patients with malignant lymphoma receiving autologous stem cell transplantation (ASCT). We retrospectively analyzed 132 malignant lymphoma patients who u
Autor:
Shingo Yano, Katsuya Yamamoto, Mai Takeuchi, Yumiko Inui, Atsuo Okamura, Mitsuhiro Ito, Kimikazu Yakushijin, Hironobu Minami, Hiroshi Matsuoka, Tohru Murayama, Tomoo Itoh, Keisuke Aiba, Takaki Shimada
Publikováno v:
Leukemia & Lymphoma. 56:3045-3051
No optimum treatment of iatrogenic immunodeficiency-associated lymphoproliferative disorders due to methotrexate in patients with rheumatoid arthritis (MTX-LPD) has yet been established, although MTX withdrawal is known to have a substantial effect o
Autor:
Zhenchang Sun, Dandan Zhang, Changsen Leng, Jiaqin Yan, Zhaoming Li, Xiaorui Fu, Yu Chang, Wencai Li, Lei Zhang, Mingzhi Zhang, Guannan Wang, Zhiyuan Zhou, Ling Li, Feifei Nan, Xin Li, Xudong Zhang, Yingying Cui, Ken Young, Xiaolong Wu
Publikováno v:
Leukemia & Lymphoma. 56:2613-2618
Potentially fatal chemotherapy (CT)-related gastrorrhagia and gastric perforation in patients with gastric lymphoma present difficult problems to doctors. We retrospectively analyzed 54 patients with ulcerative gastric diffuse large B-cell lymphoma (
Publikováno v:
Leukemia & Lymphoma. 56:910-914
Tumor fever is a common complication in patients with hematological malignancies. We retrospectively analyzed the levels of C-reactive protein (CRP) and procalcitonin (PCT) in patients with lymphoid malignancies and fever that was attributed to tumor